IP Library Granted Patent US 7,851,225
Granted Patent B2
US 7,851,225 · App. 11/948,419 · Granted Dec 14, 2010

Oxidation resistant indicator molecules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,851,225
App. No.
11/948,419
Granted
Dec 14, 2010
Kind
B2
Abstract

Compounds having enhanced oxidation stability are disclosed. The compounds have an aryl boronic acid residue having one or more electron withdrawing groups on the aromatic moiety which contains the boronic acid residue, such that the molecule has enhanced oxidation resistance as compared to a corresponding molecule without the one or more electron withdrawing groups.

Claims (83)

1. A method for using a molecule in oxidative conditions, which comprises:

a) obtaining a molecule having an aryl boronic acid residue having one or more electron withdrawing groups on the aromatic moiety which contains the boronic acid residue, such that the molecule has enhanced oxidation resistance as compared to a corresponding molecule without the one or more electron withdrawing groups; and

b) subjecting the molecule having the one or more electron withdrawing groups to oxidative conditions.

2. The method of claim 1 , wherein the electron withdrawing group comprises one or more of the following: halogen, cyano, nitro, halo substituted alkyl, carboxylic acid, ester, sulfonic acid, ketone, aldehyde, sulfonamide, sulfone, sulfonyl, sulfoxide, halo-substituted sulfone, halo-substituted alkoxy, halo-substituted ketone, amide, or combinations thereof.

3. The method of claim 1 , wherein the molecule having one or more electron withdrawing groups on the aromatic moiety further comprises a detectable group.

4. The method of claim 3 , wherein the detectable group comprises an anthracene residue.

5. The method of claim 1 , wherein the molecule having one or more electron withdrawing groups on the aromatic moiety is associated with a device that is implanted in a mammal.

6. The method of claim 5 , wherein the device determines the presence or concentration of glucose in vivo.

7. The method of claim 1 , wherein the molecule having one or more electron withdrawing groups on the aromatic moiety comprises:

9-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-3-(trifluoromethyl)benzyl]-N-[3-(methacrylamido)propyl-amino]methyl]-10-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-3-(trifluoromethyl)benzyl]-N-[2-carboxy-ethyl)amino]methyl]anthracene (4c);

9-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-3-(trifluoromethylsulfonyl)benzyl]-N-[3-(methacrylamido)propylamino]methyl]-10-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-3-(trifluoromethylsulfonyl)benzyl]-N-[2-(carboxyethyl)amino]methyl]anthracene (21);

9-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-2,4-bis(trifluoromethyl)benzyl]-N-[3-(methacrylamido)propylamino]methyl]-10-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-2,4-bis(trifluoromethyl)benzyl]-N-[2-(carboxyethyl)amino]-methyl]anthracene (27a);

or a residue or salt thereof.

8. A method for detecting the presence or concentration of an analyte in a sample in an oxidative environment, said method comprising:

a) exposing the sample to an indicator molecule having a detectable quality that changes when the indicator molecule is exposed to the analyte, said molecule comprising an aryl boronic acid residue having one or more electron withdrawing groups on the aromatic moiety which contains the boronic acid residue, such that the indicator molecule has enhanced oxidation resistance as compared to the corresponding molecule without the one or more electron withdrawing groups; and

b) measuring any change in said detectable quality to thereby determine the presence or concentration of said analyte in said sample.

9. The method of claim 8 , wherein the electron withdrawing group comprises one or more of the following: halogen, cyano, nitro, halo substituted alkyl, carboxylic acid, ester, sulfonic acid, ketone, aldehyde, sulfonamide, sulfone, sulfonyl, sulfoxide, halo-substituted sulfone, halo-substituted alkoxy, halo-substituted ketone, amide, or combinations thereof.

10. The method of claim 8 , wherein the change in the detectable quality is an optical change.

11. The method of claim 8 , wherein the analyte is glucose.

12. The method of claim 8 , wherein the molecule having one or more electron withdrawing groups on the aromatic moiety comprises:

9-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-3-(trifluoromethyl)benzyl]-N-[3-(methacrylamido)propyl-amino]methyl]-10-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-3-(trifluoromethyl)benzyl]-N-[2-carboxy-ethyl)amino]methyl]anthracene (4c);

9-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-3-(trifluoromethylsulfonyl)benzyl]-N-[3-(methacrylamido)propylamino]methyl]-10-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-3-(trifluoromethylsulfonyl)benzyl]-N-[2-(carboxyethyl)amino]methyl]anthracene (21);

9-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-2,4-bis(trifluoromethyl)benzyl]-N-[3-(methacrylamido)propylamino]methyl]-10-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-2,4-bis(trifluoromethyl)benzyl]-N-[2-(carboxyethyl)amino]-methyl]anthracene (27a);

or a residue or salt thereof.

13. A compound having the following structure:

wherein:

each Ar is an aryl group;

each R 1 and R 2 are the same or different and are an electron withdrawing group;

m and n are each independently integers from 1 to 10;

R 4 is a detectable moiety; and

each R is independently a linking group having from zero to ten contiguous or branched carbon and/or heteroatoms, with at least one R further containing a polymerizable monomeric unit;

and wherein the compound has enhanced oxidation resistance as compared to the corresponding compound without the one or more electron withdrawing groups.

14. The compound of claim 13 , wherein R 1 and R 2 each comprises one or more of the following: halogen, cyano, nitro, halo substituted alkyl, carboxylic acid, ester, sulfonic acid, ketone, aldehyde, sulfonamide, sulfone, sulfonyl, sulfoxide, halo-substituted sulfone, halo-substituted alkoxy, halo-substituted ketone, amide, or combinations thereof.

15. The compound of claim 13 , wherein R 4 comprises an anthracene residue.

16. The compound of claim 13 , wherein the compound comprises:

9-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-3-(trifluoromethyl)benzyl]-N-[3-(methacrylamido)propyl-amino]methyl]-10-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-3-(trifluoromethyl)benzyl]-N-[2-carboxy-ethyl)amino]methyl]anthracene (4c);

9-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-3-(trifluoromethylsulfonyl)benzyl]-N-[3-(methacrylamido)propylamino]methyl]-10-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-3-(trifluoromethylsulfonyl)benzyl]-N-[2-(carboxyethyl)amino]methyl]anthracene (21);

9-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-2,4-bis(trifluoromethyl)benzyl]-N-[3-(methacrylamido)propylamino]methyl]-10-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-2,4-bis(trifluoromethyl)benzyl]-N-[2-(carboxyethyl)amino]-methyl]anthracene (27a);

or a residue or salt thereof.

17. A compound having the following structure:

wherein:

each Ar is an aryl group other than phenyl;

each R 1 and R 2 are the same or different and are an electron withdrawing group;

m and n are each independently integers from 1 to 10;

R 4 is a detectable moiety; and

each R is independently a linking group having from zero to ten contiguous or branched carbon and/or heteroatoms, with at least one R containing a linking group capable of attachment to a solid support or a polymeric matrix;

and wherein the compound has enhanced oxidation resistance as compared to the corresponding compound without the one or more electron withdrawing groups.

18. The compound of claim 17 , wherein R 1 and R 2 each comprises one or more of the following: halogen, cyano, nitro, halo substituted alkyl, carboxylic acid, ester, sulfonic acid, ketone, aldehyde, sulfonamide, sulfone, sulfonyl, sulfoxide, halo-substituted sulfone, halo-substituted alkoxy, halo-substituted ketone, amide, or combinations thereof.

19. The compound of claim 17 , wherein R 4 comprises an anthracene residue.

20. A method for the production of an indicator macromolecule for detecting the presence or concentration of an analyte in an oxidative environment, said method comprising copolymerizing:

a) one or more indicator component monomers which individually are not sufficiently water soluble to permit their use in an aqueous environment for detecting the presence or concentration of said analyte, wherein the indicator component monomer comprises compound having the following structure:

wherein:

each Ar is an aryl group;

each R 1 and R 2 are the same or different and are an electron withdrawing group;

m and n are each independently integers from 1 to 10;

R 4 is a detectable moiety; and

each R is independently a linking group having from zero to ten contiguous or branched carbon and/or heteroatoms, with at least one R further containing a polymerizable monomeric unit; and

b) one or more hydrophilic monomers;

such that the resulting macromolecule is capable of detecting the presence or concentration of said analyte in an aqueous environment and wherein the compound has enhanced oxidation resistance as compared to the corresponding compound without the one or more electron withdrawing groups.

21. The method of claim 20 , wherein R 1 and R 2 each comprises one or more of the following: halogen, cyano, nitro, halo substituted alkyl, carboxylic acid, ester, sulfonic acid, ketone, aldehyde, sulfonamide, sulfone, sulfonyl, sulfoxide, halo-substituted sulfone, halo-substituted alkoxy, halo-substituted ketone, amide, or combinations thereof.

22. The method of claim 20 , wherein R 4 comprises an anthracene residue.

23. The method of claim 20 , wherein the compound comprises:

9-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-3-(trifluoromethyl)benzyl]-N-[3-(methacrylamido)propyl-amino]methyl]-10-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-3-(trifluoromethyl)benzyl]-N-[2-carboxy-ethyl)amino]methyl]anthracene (4c);

9-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-3-(trifluoromethylsulfonyl)benzyl]-N-[3-(methacrylamido)propylamino]methyl]-10-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-3-(trifluoromethylsulfonyl)benzyl]-N-[2-(carboxyethyl)amino]methyl]anthracene (21);

9-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-2,4-bis(trifluoromethyl)benzyl]-N-[3-(methacrylamido)propylamino]methyl]-10-[N-[6-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolano)-2,4-bis(trifluoromethyl)benzyl]-N-[2-(carboxyethyl)amino]-methyl]anthracene (27a);

or a residue or salt thereof.

24. A compound having the following structure:

wherein:

Ar is an aryl group;

each R 1 is the same or different and is an electron withdrawing group;

n is an integer from 1 to 10; and

R is a linking group having from zero to ten contiguous or branched carbon and/or heteroatoms, which linking group further contains a polymerizable monomeric unit and a detectable moiety;

and wherein the compound has enhanced oxidation resistance as compared to the corresponding compound without electron withdrawing group(s).

25. The compound of claim 24 , wherein R 1 comprises one or more of the following: halogen, cyano, nitro, halo substituted alkyl, carboxylic acid, ester, sulfonic acid, ketone, aldehyde, sulfonamide, sulfone, sulfonyl, sulfoxide, halo-substituted sulfone, halo-substituted alkoxy, halo-substituted ketone, amide, or combinations thereof.

26. The compound of claim 24 , wherein the detectable moiety comprises an anthracene residue.

27. A compound having the following structure:

wherein:

Ar is an aryl group;

each R 1 is the same or different and is an electron withdrawing group;

n is an integer from 1 to 10; and

R is a linking group to a chromatographic support, said linking group having from zero to ten contiguous or branched carbon and/or heteroatoms;

and wherein the compound has enhanced oxidation resistance as compared to the corresponding compound without electron withdrawing group(s).

28. The compound of claim 27 , wherein R 1 comprises one or more of the following: halogen, cyano, nitro, halo substituted alkyl, carboxylic acid, ester, sulfonic acid, ketone, aldehyde, sulfonamide, sulfone, sulfonyl, sulfoxide, halo-substituted sulfone, halo-substituted alkoxy, halo-substituted ketone, amide, or combinations thereof.

Assignments (15)
SECURITY INTEREST Recorded Sep 11, 2023
From: SENSEONICS, INCORPORATED
To: HERCULES CAPITAL, INC.
Reel/Frame 064866/0963 →
RELEASE OF SECURITY INTEREST Recorded Sep 7, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
To: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
Reel/Frame 064834/0962 →
RELEASE OF SECURITY INTEREST Recorded Apr 14, 2023
From: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
To: SENSEONICS HOLDINGS, INC.; SENSEONICS, INCORPORATED
Reel/Frame 063338/0890 →
RELEASE OF SECURITY INTEREST IN PATENTS AND TRADEMARKS Recorded Aug 14, 2020
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, COLLATERAL AGENT
To: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
Reel/Frame 053498/0275 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 14, 2020
From: SENSEONICS, INCORPORATED
To: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
Reel/Frame 053496/0292 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT - FIRST LIEN Recorded Apr 24, 2020
From: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 052492/0109 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT -SECOND LIEN Recorded Apr 24, 2020
From: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 052490/0160 →
RELEASE OF SECURITY INTEREST Recorded Mar 23, 2020
From: SOLAR CAPITAL LTD., AS AGENT
To: SENSEONICS, INCORPORATED
Reel/Frame 052207/0242 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 1, 2019
From: SENSEONICS, INCORPORATED
To: SOLAR CAPITAL LTD., AS AGENT
Reel/Frame 049926/0827 →
RELEASE OF SECURITY INTEREST Recorded Jul 25, 2019
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND AS LENDER
To: SENSEONICS, INCORPORATED
Reel/Frame 049873/0713 →
CHANGE OF NAME Recorded Jun 25, 2019
From: SENSORS FOR MEDICINE AND SCIENCE, INC.
To: SENSEONICS, INCORPORATED
Reel/Frame 049588/0046 →
SECURITY INTEREST Recorded Jan 26, 2018
From: SENSEONICS, INCORPORATED
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND AS LENDER
Reel/Frame 045164/0154 →
RELEASE OF SECURITY INTEREST Recorded Dec 12, 2011
From: NEW ENTERPRISE ASSOCIATES 10, LIMITED PARTNERSHIP
To: SENSORS FOR MEDICINE AND SCIENCE, INC.
Reel/Frame 027362/0509 →
SECURITY AGREEMENT Recorded Jan 14, 2011
From: SENSORS FOR MEDICINE AND SCIENCE, INC.
To: NEW ENTERPRISE ASSOCIATES 10, LIMITED PARTNERSHIP
Reel/Frame 025644/0315 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2007
From: COLVIN, ARTHUR E., JR.; MORTELLARO, MARK ALAN; MODZELEWSKA, ANETA
To: SENSORS FOR MEDICINE AND SCIENCE, INC.
Reel/Frame 020189/0969 →